Innovus (INNV) in Silicon Review Interview.

POISED FOR INNOVATION. The Silicon Review is the world’s most trusted online and print community for business &...
internet stock review

Innovus (INNV) Conference Call Transcript.

Q1 2019 Results, 5/15/19.  Innovus Pharmaceuticals, Inc. (OTCQB:INNV) Q1 2019 Earnings Conference Call May 15, 2019 4:15 PM...

Vaccinex (VCNX) Reports First Quarter 2019 Financial Results and Provides Corporate Update.

Updated interim data from CLASSICAL-Lung study to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in...
internet stock review

Innovus (INNV) Conference Call Today 5/15/19 at 4:15 EST.

The Company will host a conference call on Wednesday, May 15, 2019 at 4:15 p.m. ET/1:15 p.m. PT to discuss the financial...
biotech stock review, fluticare

Innovus (INNV): Twenty-Eight Drugs in Five Years. (San Diego Reader)

(Originally published 4/25/2018) “I am very steady. I like to work slowly, but surely, to get to my goal.”...
biotech stock review, innovus

Adding Innovus Pharma (INNV) $2.50 to Watch List.

Fast Growing eCommerce and Direct to Consumer Pharma Company Announces 1st Foray into CBD and 2nd Major Off-Patent Blockbuster Drug to its...
biotech stock review, zestra

Innovus Pharma (INNV) Partners With Lavasta’s 150 Member Sales Force for Female Sexual Arousal!

Dubai based Lavasta is a pharmaceutical marketing company that offers niched unique medications based on the latest scientific innovations that defy current...
Regoxidine, biotech stock review

Rogaine® Competitor Regoxidine™ Expected to Launch Second Half, 2019.

Innovus Pharma (INNV) Announces a Second Partnered United States OTC ANDA for Minoxidil 5% Foam for Men and Women.

Lift Off! Mustang Bio (MBIO) $9.31 Jumps 4-Fold.

‘Bubble Boy’ Biotech Soars 250 Percent After Cure Announcement (Bloomberg). (Bloomberg) -- Shares of the tiny biotechnology company...

Adding Vaccinex (VCNX) $5.50, to Watch List After Investor Presentation.

IPO Tumbles in Aftermarket, from $12 underwritten by Oppenheimer, BTIG and Ladenburg Thalmann, to a low of $3 in six months.

Stay connected

15,320FansLike
1,497FollowersFollow
11,182SubscribersSubscribe

Latest article

Former Tesla Foundation Vice Chairman Joins StHealth BDC.

St Health Capital Investment Corporation is delighted to announce Dr. Robert GW Brown FAPS, FIEE, FInstP, MAE as a key new member to our board...

Hercules BDC (HTGC) $13, to Present at FB Riley.

Hercules Capital to Discuss 2019 Growth Opportunities at the B. Riley FBR Institutional Investor Conference PALO ALTO, Calif.--(BUSINESS...

Innovus (INNV) in Silicon Review Interview.

POISED FOR INNOVATION. The Silicon Review is the world’s most trusted online and print community for business &...